mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.

Autor: Wege AK; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Rom-Jurek EM; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Jank P; Institute of Pathology, Philipps-University Marburg, UKGM University Hospital Marburg, Marburg, Germany., Denkert C; Institute of Pathology, Philipps-University Marburg, UKGM University Hospital Marburg, Marburg, Germany., Ugocsai P; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Solbach C; Department of Gynecology and Obstetrics, University Hospital Frankfurt, Frankfurt, Germany., Blohmer JU; Breast Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany., Sinn B; Breast Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany., van Mackelenbergh M; Department of Gynecology and Obstetrics, Schleswig-Holstein University Hospital, Kiel, Germany., Möbus V; Department of Medicine II, Hematology and Oncology, Goethe University of Frankfurt, Frankfurt, Germany., Trumpp A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), German Cancer Consortium (DKTK), Heidelberg, Germany., Marangoni E; Department of Translational Research, Institute Curie, PSL Research University, Paris, France., Pfarr N; Institute of Pathology, Technical University Munich, Munich, Germany., Irlbeck C; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Department of Experimental Medicine, University of Regensburg, Regensburg, Germany., Warfsmann J; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Department of Experimental Medicine, University of Regensburg, Regensburg, Germany., Polzer B; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Department of Experimental Medicine, University of Regensburg, Regensburg, Germany., Weber F; Institute of Pathology, University of Regensburg., Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany., Loibl S; German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany., Vladimirova V; German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany., Brockhoff G; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.

Publikováno v: International journal of cancer [Int J Cancer] 2022 Apr 15; Vol. 150 (8), pp. 1357-1372. Date of Electronic Publication: 2021 Dec 28.

Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice.

Autor: Rom-Jurek EM; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. Eva-Maria.Rom-Jurek@ukr.de., Kirchhammer N; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. nicole.kirchhammer@unibas.ch.; Department of Biomedicine, University Hospital Basel, Hebelstrasse, 204031 Basel, Switzerland. nicole.kirchhammer@unibas.ch., Ugocsai P; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. Peter.Ugoscai@ukr.de., Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. oortmann@caritasstjosef.de., Wege AK; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. Anja.Wege@ukr.de., Brockhoff G; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. gero.brockhoff@ukr.de.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2018 Feb 13; Vol. 19 (2). Date of Electronic Publication: 2018 Feb 13.

Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation.

Autor: Kim, Seung-Woo¹ (AUTHOR), Kim, Chan Woo² (AUTHOR), Kim, Hong Seok³ (AUTHOR) kimhs0622@inha.ac.kr

Publikováno v: Animal Cells & Systems. Feb2024, Vol. 28 Issue 1, p55-65. 11p.

Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury.

Autor: Dongfang Lv, Huihui Jiang, Xianzhen Yang, Yi Li, Weipin Niu, Denglu Zhang

Publikováno v: Frontiers in Immunology; 2024, p1-11, 11p

医联体模式下基层重症医师的教学实践与思考.

Autor: 王文静¹, 王铮¹, 刘昌¹, 郭波¹ bo_guo@xjtu.edu.en

Publikováno v: Journal of Modern Medicine & Health. 7/15/2020, Vol. 36 Issue 13, p2113-2116. 4p.